Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gemcitabine

5

II.a Pulmonary edema, noncardiogenic (NCPE)

2
Last update : 18/10/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR).
Respiratory medicine 2006 Apr;100;760-3 2006 Apr
[Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].
La Revue de medecine interne 2005 Mar;26;179-88 2005 Mar
Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Cancer 1998 May 01;82;1800-1 1998 May 01

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies